72 related articles for article (PubMed ID: 2355618)
1. [Clinical significance of lymphotoxin analysis].
Kasakura S
Nihon Rinsho; 1990 Feb; 48 Suppl():826-9. PubMed ID: 2355618
[No Abstract] [Full Text] [Related]
2. Lymphotoxin production in multiple sclerosis patients.
Głabiński A; Pokoca L; Tchórzewski H; Selmaj K
Arch Immunol Ther Exp (Warsz); 1991; 39(3):285-90. PubMed ID: 1810221
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of lymphocytotoxins in rheumatoid arthritis in comparison with clinical course and other antibody activities.
Steffen C; Thumb N; Frank O; Eberl R; Tausch G; Boros M
Z Immunitatsforsch Exp Klin Immunol; 1973 Jun; 145(4):303-11. PubMed ID: 4282949
[No Abstract] [Full Text] [Related]
4. [Lymphotoxin (lymphotoxin/TNF-beta)].
Abe Y; Takeuchi T; Kito K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():86-8. PubMed ID: 16149459
[No Abstract] [Full Text] [Related]
5. [Lymphotoxin (LT)].
Kasakura S
Nihon Rinsho; 1995 Mar; 53 Su Pt 2():835-8. PubMed ID: 8753372
[No Abstract] [Full Text] [Related]
6. Detection of lymphotoxins in vivo. I. Specific identification of short-lived LT activity in the plasma of various human patients employing rabbit anti-human LT sera in vitro.
Granger GA; Shimizu I; Harris L; Andreson J; Horn P
Clin Immunol Immunopathol; 1978 May; 10(1):104-15. PubMed ID: 350462
[No Abstract] [Full Text] [Related]
7. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
8. Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance.
Toussirot E; Pertuiset E; Martin A; Melac-Ducamp S; Alcalay M; Grardel B; Seror P; Perdriger A; Wendling D; Mulleman D; Beraneck L; Mariette X;
J Rheumatol; 2006 May; 33(5):1027-8. PubMed ID: 16541474
[No Abstract] [Full Text] [Related]
9. [Immunologic abnormalities during treatment with penicillamine].
Recordier AM; Roux H; Mercier P; Maestracci D; Schiano A
Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):566-70. PubMed ID: 64126
[No Abstract] [Full Text] [Related]
10. True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?
Buch MH; Conaghan PG; Quinn MA; Bingham SJ; Veale D; Emery P
Ann Rheum Dis; 2004 Oct; 63(10):1344-6. PubMed ID: 15033655
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulins on the surface of lymphocytes in autoimmune disease. II. Lymphocytotoxins on the surface of lymphocytes.
Gergely P; Szegedi G; Stenszky E; Fekete B; Szabó G; Petrányi G
Acta Med Acad Sci Hung; 1974; 31(1-2):115-8. PubMed ID: 4549467
[No Abstract] [Full Text] [Related]
12. Rheumatoid arthritis and multiple sclerosis in the same patient. Two case-reports.
Attout H; Toussirot E; Augé B; Chavot D; Wendling D
Rev Rhum Engl Ed; 1999 Mar; 66(3):169-72. PubMed ID: 10327497
[TBL] [Abstract][Full Text] [Related]
13. [Irregular agglutinins, hemolysins, antilymphocyte antibodies, serum anticomplementarity, human and species antiglobulins and cryoglobulins in a series of 33 patients with rheumatoid arthritis].
Mercier P; Roux H; Maestracci D; Melis C; Recordier AM
Rev Rhum Mal Osteoartic; 1975 Apr; 42(4):239-45. PubMed ID: 806957
[TBL] [Abstract][Full Text] [Related]
14. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?
Robinson WH; Genovese MC; Moreland LW
Arthritis Rheum; 2001 Sep; 44(9):1977-83. PubMed ID: 11592357
[No Abstract] [Full Text] [Related]
15. [Cold lymphocytotoxins: their relationship with various physiological and pathological conditions].
Mayer S; Falkenrodt A; Tongio MM
Ann Immunol (Paris); 1975; 126(5-6):621-7. PubMed ID: 1084128
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of antinuclear antibodies.
Rothfield NF
J Med Assoc Ga; 1967 Dec; 56(12):491-4. PubMed ID: 4866469
[No Abstract] [Full Text] [Related]
17. Lymphotoxin, a biologically relevant model lymphokine.
Ruddle NH; Powell MB; Conta BS
Lymphokine Res; 1983; 2(1):23-31. PubMed ID: 6206361
[No Abstract] [Full Text] [Related]
18. [Study of cellular immunity in multiple sclerosis].
Caputo D; Zibetti A; Manara F; Bisaccia G
Minerva Med; 1977 Feb; 68(6):413-6. PubMed ID: 300150
[No Abstract] [Full Text] [Related]
19. Cytokine-modifying therapies in immune disorders.
Romanelli F
JAAPA; 2002 Feb; 15(2):25-8, 31-4. PubMed ID: 11917757
[No Abstract] [Full Text] [Related]
20. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells.
Garrett IR; Durie BG; Nedwin GE; Gillespie A; Bringman T; Sabatini M; Bertolini DR; Mundy GR
N Engl J Med; 1987 Aug; 317(9):526-32. PubMed ID: 3497347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
